LOCOID
LOE ApproachingNDATOPICALSOLUTION
Approved
Feb 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 10h ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LOCOID is a topical solution approved in 1987 by Bausch + Lomb for dermatological indications. The generic name and mechanism of action are not specified in available data. This is a mature NDA product in solution formulation for direct skin application.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30), indicating potential team contraction or strategic repositioning ahead.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings suggest limited active hiring for this product, typical of a mature brand approaching LOE. Career opportunities are concentrated in defensive commercial roles focused on market retention and generic transition planning.
Brand ManagerField Sales Representative
Worked on LOCOID at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.